Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate
Researchers have developed a new vaccine candidate that is specifically targeted against the SARS-CoV-2 Omicron variant.
Delta Rbds Yale University School Of Medicine Yale University School Omicron Hexapro Coronavirus Disease Covid 19 Ars Cov 2
Source: news-medical.net